NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Concentric Analgesics

Concentric Analgesics

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.concentricanalgesics.com/

Last Round

Convertible Debt

Jan 26, 2022

Total Funding Raised

$113.4M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Concentric Analgesics is a biopharmaceutical company that develops and commercializes non-opioid therapeutics for the management of postoperative and chronic pain.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

non-opioid pain managementpost-surgical painsustained-releaselocal anestheticdrug delivery platformcapsaicin prodrugopioid alternativesbiopharmaceuticalclinical-stage biotechhydrogel technologypain therapeuticsnon-narcotic pain reliefTRPV1surgical pain relief

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Concentric Analgesics Comps

Public and private peers based on sector, stage, and business model.

Concentric Analgesics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Concentric Analgesics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtJan 26, 2022
Series BMay 21, 2019
Series ADec 1, 2016

Key People

Founding team and executive leadership

John Donovan

President And Chief Scientific Officer, Founder, President And Chief Scientific Officer

Founding Team

Frank Bellizzi

Chief Executive Officer

Executive Team

Concentric Analgesics Investors

Notable investors and investment history

Concentric Analgesics investors
InvestorRounds
TD SecuritiesSeries B
Blue Owl CapitalSeries B
Kern Whelan CapitalSeries B
Oracle Investment ManagementSeries B
VenrockSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors increased 117% MoM.

Concentric Analgesics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Concentric Analgesics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Concentric Analgesics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range4
Year Founded2014
Last FundingJan 26, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.